BTI AGM Notice Neutral

BRITISH AMERICAN TOBACCO PLC - AGM 2026 - Chairs address

British American Tobacco p.l.c.
Full analysis

What this filing means

British American Tobacco's AGM address affirms its £1.3 billion buy-back and deleveraging targets, though near-term earnings face a 2-3% FX headwind and performance is expected at the lower end of guidance.

The Chairman of BAT confirmed the company is generating strong cash flow and rewarding shareholders with buybacks and dividends. However, current year profits might be slightly squeezed by currency exchange rates and the need to invest more in new products.

Bull case

  • The company announced a 2% dividend increase and a £1.3 billion share buy-back, underscoring strong capital return commitments.
  • Cash generation remains robust, with expectations to deliver over £50 billion of free cash flow between 2024 and 2030.
  • Deleveraging is progressing on schedule, targeting a 2-2.5x leverage range by year-end.
  • Operational momentum is visible in New Categories, with Smokeless product consumers growing over 15% year-on-year.

Bear case

  • Management anticipates full-year performance to land at the lower end of guided ranges due to APMEA stabilization and ongoing innovation investments.
  • The extension of the Chair's tenure beyond nine years marks a formal departure from the UK Corporate Governance Code recommendations.
  • A translational FX headwind of 2% to 3% is expected to drag on adjusted diluted EPS for the half-year and full-year.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

The AGM Chair's address confirms a £1.3 billion share buy-back, a 2% dividend increase, and reiterates the target of reaching 2-2.5x leverage by year-end. While the commitment to structural cash returns and deleveraging supports the long-term thesis, near-term momentum is tempered by management's expectation to land at the lower end of guided ranges alongside a 2-3% translational FX headwind. This update is not a formal earnings release or a change in the medium-term strategic algorithm, but rather a progress check on previously announced operational targets. Investor Takeaway: Robust cash generation and deleveraging provide a solid valuation floor at a 12.1x trailing P/E and 5.69% yield, though immediate upside may be capped by the guided lower-end operational performance and currency drags.

Routine filing affirming existing guidance ranges. Useful as thesis confirmation, but does not trigger fresh directional conviction.

Decision framework

Current stance: Filing Positive

Key drivers

  • The company announced a 2% dividend increase and a £1.3 billion share buy-back, underscoring strong capital return commitments.
  • Cash generation remains robust, with expectations to deliver over £50 billion of free cash flow between 2024 and 2030.
  • Deleveraging is progressing on schedule, targeting a 2-2.5x leverage range by year-end.

Key risks

  • Management anticipates full-year performance to land at the lower end of guided ranges due to APMEA stabilization and ongoing innovation investments.
  • The extension of the Chair's tenure beyond nine years marks a formal departure from the UK Corporate Governance Code recommendations.
  • A translational FX headwind of 2% to 3% is expected to drag on adjusted diluted EPS for the half-year and full-year.

What would change the view

  • Forward guidance is cut or withdrawn in the next update.
  • Cash-flow conversion deteriorates relative to reported earnings.
  • Positive thesis fails to hold through the next reporting window.

Evidence from the filing

  • The company maintains a strong commitment to shareholder returns, having announced a 2% dividend increase and a £1.3 billion share buy-back for the year.

    “This year, we have announced a 2% dividend increase and a £1.3 billion share buy-back.”
  • BAT continues to demonstrate high cash generation, with an expectation to deliver over £50 billion of free cash flow between 2024 and 2030.

    “BAT continues to be highly cash generative, and we expect to deliver over £50 billion of free cash flow between 2024 and 2030.”
  • The company is successfully executing its deleveraging strategy, remaining on track to reach its 2-2.5x target leverage range by year-end.

    “We remain on track with deleveraging and expect to be within our 2-2.5x target leverage range** by year-end.”
  • Operational momentum is evidenced by a 15% year-on-year increase in consumers choosing Smokeless products and a return to growth in the U.S. market.

    “The number of consumers choosing our Smokeless1 products increased by more than 15% year-on-year, taking us closer to our target of 50 million consumers by 2030;”
  • The company explicitly expects performance at the lower end of its guided ranges, citing the ongoing struggle to stabilize the APMEA region and the necessity of continued investment in premium innovation.

    “We continue to expect performance at the lower end of our guided ranges this year, reflecting the time required to stabilise the APMEA region and our continued investment behind premium innovation roll-outs.”
  • The Chair's decision to extend their tenure beyond the nine-year limit set by the UK Corporate Governance Code introduces a governance red flag regarding board independence and succession planning.

    “An extension of my tenure, beyond July 2026, represents a departure from the nine-year recommendation set out in the UK Corporate Governance Code.”
  • Shareholders face a translational FX headwind of 2% to 3% on adjusted diluted EPS, which acts as a direct drag on earnings growth in the current financial year.

    “At current rates, we now expect a translational FX headwind on adjusted diluted EPS** in the range of 2% to 3% for the half-year and the full-year.”
Category
AGM Notice
Event posture
No Edge
Published
Apr 15, 2026

More on British American Tobacco p.l.c.

Related filings